Skip to main content

Advertisement

Log in

Guidance and control of percutaneous treatments with contrast-enhanced ultrasound

  • Contrast Ultrasound: A New Modality for Abdominal Imaging
  • Published:
European Radiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Dodd GD 3rd, Soulen MC, Kane RA et al (2000) Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough. Radiographics 20:9–27

    PubMed  Google Scholar 

  2. Goldberg SN, Gazelle GS, Compton CC, Mueller PR, Tanabe KK (2000) Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer 88:2452–2463

    Article  PubMed  CAS  Google Scholar 

  3. Chopra S, Dodd GD 3rd, Chintapalli KN, Leyendecker JR, Karahan OI, Rhim H (2001) Tumor recurrence after radiofrequency thermal ablation of hepatic tumors: spectrum of findings on dual-phase contrast-enhanced CT. AJR 177:381–387

    PubMed  CAS  Google Scholar 

  4. De Baere T, Elias D, Dromain C et al (2000) Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. AJR 175:1619–1627

    PubMed  Google Scholar 

  5. Solbiati L, Tonolini M, Cova L, Goldberg SN (2001) The role of contrast-enhanced ultrasound in the detection of focal liver lesions. Eur Radiol 11 [Suppl 3] E15-E26

    Article  PubMed  Google Scholar 

  6. Rhim H, Goldberg SN, Dodd Gd 3rd, Solbiati L, Lim HK, Tonolini M, Cho OK (2001) Essential techniques for successful radiofrequency thermal ablation of malignant hepatic tumors. Radiographics 21:S17–31

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Solbiati, L., Ierace, T., Tonolini, M. et al. Guidance and control of percutaneous treatments with contrast-enhanced ultrasound. Eur Radiol 13 (Suppl 3), N87–N90 (2003). https://doi.org/10.1007/s00330-003-0013-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-003-0013-1

Keywords

Navigation